Is healthcare innovation threatened by superbugs?

  01 December 2021

It sounds like something out of a science fiction novel, but this question is not so far removed from our modern-day reality. Antimicrobial resistance (AMR) has the potential to change the way we can rely on modern medicine. Everything from tooth extraction to chemotherapy can start carrying undesirable risks.  

AMR is a natural process where pathogens such as bacteria grow a resistance to the medicines, namely antimicrobials, which are our only defence to fight them. This process can create what we often refer to as superbugs. An OECD study showed that AMR proportions have been increasing across the EU/EEA between 2005 and 2015, close to one in five infections in the EU/EEA is due to antibiotic-resistant bacteria. In some countries, like Romania and Greece, about 40% of infections are due to antibiotic-resistant bacteria.

Further reading: European Liberal Forum
Author(s): European Liberal Forum
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed